II. Prospects for development of new anitimicrobials for clinical control of tuberculosis: 4. Clinical evaluation of new quinolones as antituberculosis drugs

Kekkaku

Volumn 74, Issue 1, 1999, Pages 71-75

  Kawahara, Shin ^a   Tada, Atsuhiko ^b   Nagare, Hitoshi ^b  

^a National Hospital Organization   (Japan)

^b NONE

Author keywords

Antituberculosis drugs; Clinical evaluation; New quinolones

Indexed keywords

1 CYCLOPROPYL 8 DIFLUOROMETHOXY 6 FLUORO 1,4 DIHYDRO 7 (3 METHYL 1 PIPERAZINYL) 4 OXO 3 QUINOLINECARBOXYLIC ACID; APARFLOXACIN; CIPROFLOXACIN; ETHAMBUTOL; GATIFLOXACIN; ISONIAZID; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SITAFLOXACIN; SPARFLOXACIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; CROSS RESISTANCE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PHARMACOKINETICS; SIDE EFFECT; TUBERCULOSIS; CLINICAL TRIAL; REVIEW;

ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; CLINICAL TRIALS; FLUOROQUINOLONES; HUMANS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0032611010     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Tsukamura M : In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280). Am Rev Respir Dis. 1985 ; 131 : 348-351.
2. Tsukamura M, Nakamura E, Yoshii S, et al. : Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis. Am Rev Respir Dis. 1985 ; 131 : 352-356.
3. Yew WW, Kwan SY, Ma WK, et al. : In vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis. J Antimicrob Chemother. 1990 ; 26 : 227-236.
4. Kahara LM and Spino M : Ciprofloxacin in patients with mycobacterial infections : experience in 15 patients. DICP. 1991 ; 25 : 919-924.
5. Kennedy N, Fox R, Uiso L, et al. : Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis. J Antimicrob Chemotherapy. 1993 ; 32 : 897-902.
6. Rao S : An uncontrolled trial of pefloxacin in the retreatment of patients with pulmonary tuberculosis. Tuberc Lung Dis. 1995 ; 76 : 219-222.
7. Kohno S, Koga H, Kaku M, et al. : Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis. Chest, 1992 ; 102 : 1815-1818.
8. Mohanty KC and Dhamgaye TM : Controlled trial of ciprofloxacin in short-term chemotherapy for pulmonary tuberculosis. Chest. 1993 ; 104 : 1194-1198.
9. Kennedy N, Berger L, Curram J, et al. : Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin Infect Dis. 1996 ; 22 : 827-833.